Kindred Healthcare's (NYSE:KND) attempts to buy Gentiva (NASDAQ:GTIV) seem to keep hitting the skids. First there were the multiple board rejections. And now rumors abound that Gentiva is looking to buy out fellow hospice and home health company Amedisys (NASDAQ:AMED). How credible are the rumors?

Credible enough that Kindred sent Gentiva a note decrying the potential of this "value-destroying and highly levered transaction." And Kindred's management made clear that they may pull their offer if the Amedisys buyout occurs.

So, should Gentiva buy Amedisys? Should Kindred buy Gentiva?

Motley Fool health care analysts Michael Douglass and David Williamson answer in the video below.

David Williamson has no position in any stocks mentioned. Michael Douglass has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.